256 related articles for article (PubMed ID: 11011004)
1. Neurotoxicity of HIV-1 proteins gp120 and Tat in the rat striatum.
Bansal AK; Mactutus CF; Nath A; Maragos W; Hauser KF; Booze RM
Brain Res; 2000 Oct; 879(1-2):42-9. PubMed ID: 11011004
[TBL] [Abstract][Full Text] [Related]
2. Differential long-term neurotoxicity of HIV-1 proteins in the rat hippocampal formation: a design-based stereological study.
Fitting S; Booze RM; Hasselrot U; Mactutus CF
Hippocampus; 2008; 18(2):135-47. PubMed ID: 17924522
[TBL] [Abstract][Full Text] [Related]
3. Synergistic neurotoxicity of opioids and human immunodeficiency virus-1 Tat protein in striatal neurons in vitro.
Gurwell JA; Nath A; Sun Q; Zhang J; Martin KM; Chen Y; Hauser KF
Neuroscience; 2001; 102(3):555-63. PubMed ID: 11226693
[TBL] [Abstract][Full Text] [Related]
4. EGCG mitigates neurotoxicity mediated by HIV-1 proteins gp120 and Tat in the presence of IFN-gamma: role of JAK/STAT1 signaling and implications for HIV-associated dementia.
Giunta B; Obregon D; Hou H; Zeng J; Sun N; Nikolic V; Ehrhart J; Shytle D; Fernandez F; Tan J
Brain Res; 2006 Dec; 1123(1):216-225. PubMed ID: 17078933
[TBL] [Abstract][Full Text] [Related]
5. Apoptotic death of striatal neurons induced by human immunodeficiency virus-1 Tat and gp120: Differential involvement of caspase-3 and endonuclease G.
Singh IN; Goody RJ; Dean C; Ahmad NM; Lutz SE; Knapp PE; Nath A; Hauser KF
J Neurovirol; 2004 Jun; 10(3):141-51. PubMed ID: 15204919
[TBL] [Abstract][Full Text] [Related]
6. Human immunodeficiency virus-1 Tat protein and methamphetamine interact synergistically to impair striatal dopaminergic function.
Maragos WF; Young KL; Turchan JT; Guseva M; Pauly JR; Nath A; Cass WA
J Neurochem; 2002 Nov; 83(4):955-63. PubMed ID: 12421368
[TBL] [Abstract][Full Text] [Related]
7. Intravenous cocaine abuse: a rodent model for potential interactions with HIV proteins.
Bansal AK; Mactutus CF; Nath A; Anderson C; Booze RM
Adv Exp Med Biol; 2001; 493():241-5. PubMed ID: 11727772
[No Abstract] [Full Text] [Related]
8. Inhibition of mixed lineage kinase 3 prevents HIV-1 Tat-mediated neurotoxicity and monocyte activation.
Sui Z; Fan S; Sniderhan L; Reisinger E; Litzburg A; Schifitto G; Gelbard HA; Dewhurst S; Maggirwar SB
J Immunol; 2006 Jul; 177(1):702-11. PubMed ID: 16785569
[TBL] [Abstract][Full Text] [Related]
9. Neonatal intrahippocampal injection of the HIV-1 proteins gp120 and Tat: differential effects on behavior and the relationship to stereological hippocampal measures.
Fitting S; Booze RM; Mactutus CF
Brain Res; 2008 Sep; 1232():139-54. PubMed ID: 18674522
[TBL] [Abstract][Full Text] [Related]
10. Synaptic transport of human immunodeficiency virus-Tat protein causes neurotoxicity and gliosis in rat brain.
Bruce-Keller AJ; Chauhan A; Dimayuga FO; Gee J; Keller JN; Nath A
J Neurosci; 2003 Sep; 23(23):8417-22. PubMed ID: 12968004
[TBL] [Abstract][Full Text] [Related]
11. Tat mediates apoptosis in vivo in the rat central nervous system.
Gavriil ES; Cooney R; Weeks BS
Biochem Biophys Res Commun; 2000 Jan; 267(1):252-6. PubMed ID: 10623606
[TBL] [Abstract][Full Text] [Related]
12. Estrogen attenuates gp120- and tat1-72-induced oxidative stress and prevents loss of dopamine transporter function.
Wallace DR; Dodson S; Nath A; Booze RM
Synapse; 2006 Jan; 59(1):51-60. PubMed ID: 16237680
[TBL] [Abstract][Full Text] [Related]
13. Brain-derived neurotrophic factor prevents human immunodeficiency virus type 1 protein gp120 neurotoxicity in the rat nigrostriatal system.
Mocchetti I; Nosheny RL; Tanda G; Ren K; Meyer EM
Ann N Y Acad Sci; 2007 Dec; 1122():144-54. PubMed ID: 18077570
[TBL] [Abstract][Full Text] [Related]
14. Ceftriaxone protects against the neurotoxicity of human immunodeficiency virus proteins.
Rumbaugh JA; Li G; Rothstein J; Nath A
J Neurovirol; 2007 Apr; 13(2):168-72. PubMed ID: 17505985
[TBL] [Abstract][Full Text] [Related]
15. Involvement of cytokines in human immunodeficiency virus-1 protein Tat and methamphetamine interactions in the striatum.
Theodore S; Cass WA; Maragos WF
Exp Neurol; 2006 Jun; 199(2):490-8. PubMed ID: 16510141
[TBL] [Abstract][Full Text] [Related]
16. Oxidative damage induced by the injection of HIV-1 Tat protein in the rat striatum.
Aksenov MY; Hasselrot U; Bansal AK; Wu G; Nath A; Anderson C; Mactutus CF; Booze RM
Neurosci Lett; 2001 Jun; 305(1):5-8. PubMed ID: 11356294
[TBL] [Abstract][Full Text] [Related]
17. Increased vulnerability of ApoE4 neurons to HIV proteins and opiates: protection by diosgenin and L-deprenyl.
Turchan-Cholewo J; Liu Y; Gartner S; Reid R; Jie C; Peng X; Chen KC; Chauhan A; Haughey N; Cutler R; Mattson MP; Pardo C; Conant K; Sacktor N; McArthur JC; Hauser KF; Gairola C; Nath A
Neurobiol Dis; 2006 Jul; 23(1):109-19. PubMed ID: 16697650
[TBL] [Abstract][Full Text] [Related]
18. Methamphetamine and human immunodeficiency virus protein Tat synergize to destroy dopaminergic terminals in the rat striatum.
Theodore S; Cass WA; Maragos WF
Neuroscience; 2006 Feb; 137(3):925-35. PubMed ID: 16338084
[TBL] [Abstract][Full Text] [Related]
19. The immunophilin ligand GPI1046 protects neurons from the lethal effects of the HIV-1 proteins gp120 and Tat by modulating endoplasmic reticulum calcium load.
Caporello E; Nath A; Slevin J; Galey D; Hamilton G; Williams L; Steiner JP; Haughey NJ
J Neurochem; 2006 Jul; 98(1):146-55. PubMed ID: 16805804
[TBL] [Abstract][Full Text] [Related]
20. HIV-1 Tat neurotoxicity in primary cultures of rat midbrain fetal neurons: changes in dopamine transporter binding and immunoreactivity.
Aksenova MV; Silvers JM; Aksenov MY; Nath A; Ray PD; Mactutus CF; Booze RM
Neurosci Lett; 2006 Mar; 395(3):235-9. PubMed ID: 16356633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
